- Filed
- Jan 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Dec 30, 2025 | 15.34M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2025 | 15.34M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2024 | 15.34M sh |
| Operating Cash Flow | Q1 2026 · Nov 30, 2025 | −$28.32K |
| Operating Cash Flow | Q1 2026 · Nov 30, 2024 | −$39.4K |
| Stockholders Equity | Q1 2026 · Nov 30, 2025 | $551 |
| Stockholders Equity | Q1 2026 · Aug 31, 2025 | $15.79K |
| Stockholders Equity | Q1 2026 · Nov 30, 2024 | $23.47K |
| Stockholders Equity | Q1 2026 · Aug 31, 2024 | $54.44K |
| Current Liabilities | Q1 2026 · Nov 30, 2025 | $16.42K |
| Current Liabilities | Q1 2026 · Aug 31, 2025 | $27.39K |
| Total Liabilities | Q1 2026 · Nov 30, 2025 | $16.42K |
| Total Liabilities | Q1 2026 · Aug 31, 2025 | $27.39K |
| Current Assets | Q1 2026 · Nov 30, 2025 | $14.62K |
| Current Assets | Q1 2026 · Aug 31, 2025 | $40.63K |
| Total Assets | Q1 2026 · Nov 30, 2025 | $16.97K |
| Total Assets | Q1 2026 · Aug 31, 2025 | $43.18K |
| Eps Diluted | Q1 2026 · Nov 30, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Nov 30, 2024 | $0.00 |
| Sga Expense | Q1 2026 · Nov 30, 2025 | $15.24K |
| Sga Expense | Q1 2026 · Nov 30, 2024 | $30.97K |
| Net Income | Q1 2026 · Nov 30, 2025 | −$15.24K |
| Net Income | Q1 2026 · Nov 30, 2024 | −$30.97K |